z-logo
open-access-imgOpen Access
Elongational stalling activates mitoribosome-associated quality control
Author(s) -
Nirupa Desai,
Hanting Yang,
Viswanathan Chandrasekaran,
R. Kazi,
Michal Minczuk,
V. Ramakrishnan
Publication year - 2020
Publication title -
science
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 12.556
H-Index - 1186
eISSN - 1095-9203
pISSN - 0036-8075
DOI - 10.1126/science.abc7782
Subject(s) - mitochondrial ribosome , ribosome , biology , microbiology and biotechnology , elongation factor , translocase , biochemistry , rna , gene , chromosomal translocation
Quality control in mitochondria Human mitochondria have their own genome and ribosomes called mitoribosomes that respectively encode and synthesize essential subunits of complexes that use the energy from the oxidation of metabolites to drive the synthesis of adenosine triphosphate (ATP). These complexes are key to the health of the cell. Desaiet al. studied a mitoribosome-associated quality control pathway that prevents aberrant translation. They purified mitoribosomes under conditions designed to induce stalling and determined the structures of two intermediates in the rescue pathway. These structures revealed two proteins that eject the unfinished polypeptide chain and peptidyl transfer RNA from the ribosome. Their cryo–electron microscopy dataset also revealed additional states that may correspond to intermediates in the mitochondrial translation elongation cycle.Science , this issue p.1105

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom